RxDoctor Payments Data

William Pridgen, MD

Surgery · Tuscaloosa, ALNPI 1629017736

Payments from drug & device makers

$890in general payments, 2019–2025

Across 26 payments — averaging $34.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$465
  • Axsome Therapeutics, Inc.$130
  • Takeda Pharmaceuticals U.S.A., Inc.$123
  • Stryker$51
  • CSL Behring$38
  • Vertex$38
  • plus $46 from 2 others

What the payments were for

  • Travel & lodging$192%
  • Food & beverage$78488%
  • Education$799%
  • Gifts$91%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$890 in reported general payments places this provider in the 35th percentile of 382 surgery providers in Alabama.

See all surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$44,896
Medicare patients
96
Services billed
335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nucynta ErTapentadol Hcl79$125,225
ValacyclovirValacyclovir Hcl497$48,024
TrintellixVortioxetine Hydrobromide52$32,565
Famciclovir202$24,805
Celecoxib560$20,844
AuvelityDextromethorphan Hbr/Bupropion13$10,436
Dexlansoprazole DrDexlansoprazole47$10,328
Tramadol Hcl ErTramadol Hcl101$7,554
Duloxetine Hcl288$5,043
Colestipol Hcl34$3,981
Sucralfate57$3,231
Mometasone Furoate32$3,198
Tramadol Hcl257$2,506
Clonazepam164$1,619
Acyclovir50$1,389

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$123$32,56552 claims
Axsome Therapeutics, Inc.Auvelity$130$10,43613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 382 surgery providers in Alabama.

Other surgery in Tuscaloosa

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →